Register Now: IKRIS Breast Cancer Awareness Run 2022

Featured Post

2 mins read

Is there any link between Psoriasis and Thyroid Disease?

According to a review study published in Cureus, “Multiple findings demonstrated a positive link between psoriasis and thyroid diseases, including […]

ikrisuser
April 15, 2021
2 mins read

Food and Drug Administration Approves CAR T-Cell Therapy for Multiple Myeloma

The first cell-based gene therapy for multiple myeloma has been approved by the US Food and Drug Administration. Approval of […]

ikrisuser
April 15, 2021
2 mins read

Cost-effectiveness of Daratumumab (Darzalex) for Adult Patients with RRMM

According to research published in Frontiers in Pharmacology, Addition of daratumumab (darzalex) to the standard care may help in order […]

ikrisuser
April 14, 2021
2 mins read

5-Minutes Novel Breast Cancer Treatment Rolled Out in UK by National Health Service

A novel breast cancer jab will lessen the time period patients have to pass in hospital from two-and-a-half hours to […]

ikrisuser
April 8, 2021
2 mins read

The US FDA approves Sarclisa together with Carfilzomib and Dexamethasone for Relapsed/Refractory Multiple Myeloma

The FDA has approved Sarclisa, together with Kyprolis and dexamethasone (Kd), in order to treat adult patients with the relapsed […]

ikrisuser
April 5, 2021
2 mins read

A combination of a couple of existing drugs can kill cancer cells

Preclinical investigation from VCU Massey Cancer Center published recently in the Proceedings of the National Academy of Sciences demonstrates that […]

ikrisuser
April 2, 2021
3 mins read

Exploring the Potential of PSCA-Targeted Chimeric Antigen Receptor T-Cell Therapy in Order to Treat mCRPC

The mCRPC (Metastatic Castration-Resistant Prostate Cancer) remains a sort of deadly disease despite the improved treatment options for patients progressing […]

ikrisuser
March 30, 2021
< 1 min read

NICE recommends a triplet therapy comprised of Kyprolis, lenalidomide and dexamethasone for MM

The NICE has specifically recommended a triplet therapy comprised of Kyprolis (carfilzomib), lenalidomide and dexamethasone in order to treat previously […]

ikrisuser
March 23, 2021
2 mins read

Boston Scientific has received US FDA approval of the TheraSphere (Y-90 Glass Microspheres) for the treatment of HCC

Boston Scientific has received US FDA approval of the TheraSphere (Y-90 Glass Microspheres), originated for the treatment of patients with […]

ikrisuser
March 19, 2021
6 mins read

Triplet regimen of melphalan flufenamide with dexamethasone and either daratumumab or bortezomib for RRMM

According to phase-I/IIa findings from the ANCHOR (OP-104) trial that were introduced during the second EMN (European Myeloma Network) Meeting, […]

ikrisuser
March 18, 2021
We Offer You

Partnership

We love to partner with brands and products that we believe in. If you feel that your company shares values and would benefit our readers, we would love to talk about working together.

Learn More